One Month Remains to Register for the cGMP Regulatory Inspections Course - Through the Eyes of FDA, EMA and PMDA (March 7, 2023)
06 févr. 2023 05h43 HE
|
Research and Markets
Dublin, Feb. 06, 2023 (GLOBE NEWSWIRE) -- The "cGMP Regulatory Inspections - Through the Eyes of FDA, EMA and PMDA" training has been added to ResearchAndMarkets.com's offering. GMP-compliance is...
Australia Allows Prescription of MDMA and Psilocybin in Groundbreaking Regulatory Change
03 févr. 2023 00h01 HE
|
PharmAla Biotech
VANCOUVER, British Columbia, Feb. 03, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) applauds the Australian Therapeutic Goods Administration (TGA) in allowing for...
2 Day Online Course on Aseptic Processing in the Manufacture of Pharmaceutical and Biotech Products (February 2-3, 2023)
30 déc. 2022 04h58 HE
|
Research and Markets
Dublin, Dec. 30, 2022 (GLOBE NEWSWIRE) -- The "2 Day Course on Aseptic Processing in the Manufacture of Pharmaceutical and Biotech Products 22" training has been added to ResearchAndMarkets.com's...
Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment: 2 Day Issues and Solutions Training Course (January 23-24, 2023)
30 déc. 2022 04h38 HE
|
Research and Markets
Dublin, Dec. 30, 2022 (GLOBE NEWSWIRE) -- The "Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment - Issues and Solutions Training Course" training has been added to ...
Dipharma receives GMP certification from Brazilian ANVISA
01 déc. 2022 08h46 HE
|
Dipharma Francis S.R.L
MILAN, Italy, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Dipharma Francis S.r.l. (Dipharma), a leading Contract Development and Manufacturing Organization (CDMO) and a global manufacturer of Active...
RespireRx Pharmaceuticals Inc. Announces Entry into Letter of Intent with Australian Headquartered CRO for Dronabinol Development for Obstructive Sleep Apnea
17 nov. 2022 08h45 HE
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Nov. 17, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Pink Market:RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
Mindset Pharma and PharmAla Biotech Enter into Exclusive Sales Agreement
16 nov. 2022 07h30 HE
|
PharmAla Biotech
VANCOUVER, British Columbia, Nov. 16, 2022 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA), a biotechnology company focused on the research, development, and manufacturing...
GMP Testing Service Global Market Report 2022: Continuous Proliferation of Pharmaceuticals Industry Drives Growth
07 nov. 2022 08h58 HE
|
Research and Markets
Dublin, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The "GMP Testing Service Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Service Type and End User" report has been added to ...
Harro Höfliger and LEON collaborate to bring the innovative NANOus LNP-encapsulation device to market for rapid, large-scale prophylactic vaccine manufacturing
26 oct. 2022 05h00 HE
|
Leon-nanodrugs GmbH
LEON and Harro Höfliger to build and commercialize LEON’s NANOus, a novel aseptic manufacturing device to facilitate commercial production of LNP-encapsulated genetic materials and other APIsBy...
Brains Bioceutical Opens UK’s Largest EU GMP-Grade Licensed Cannabinoid Research and Commercial Production Facility
29 sept. 2022 01h00 HE
|
Brains Bioceutical Corp
VANCOUVER, British Columbia and SANDWICH, United Kingdom, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp (“Brains” or the “Company”), is pleased to announce the opening of its recently...